CD37 Antikörper
Kurzübersicht für CD37 Antikörper (ABIN7865743)
Target
Alle CD37 (TSPAN26) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- anti-CD37 mouse monoclonal, IPO-24, purified
-
Aufreinigung
- affinity chromatography
-
Immunogen
- spleen cells of a patient with hairy cell leukemia
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- store at 2 - 8 °C
-
-
- CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))
-
Andere Bezeichnung
- CD37
-
Hintergrund
- IPO-24 reacts with CD37, a B lineage restricted antigen, strongly expressed throughout B-cell ontogeny from pre B-cell until plasmablasts. Plasma cells are negative. IPO-24 reacts with human B-cell lines Daudi, Raji, Namalva, Ramos and CABIL, whereas T-cell lines CEM, Molt-4, Jurkat, MT-4, H9 and non-lymphoid cell lines MeWo and A-431 are negative. IPO-24 stains B-cell follicles and the most strongly labelled elements are mantle zone lymphoid cells. Neutrophils, macrophages, thymocytes and dendritic reticulum cells are negative. Positive control: Daudi, Raji, Namalva and CABIL cells, human tonsil or lymph node.
-
Pathways
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-